ORAMED PHARMACEUTICALS INC
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
ORMP$3.86-0.8%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. - FINANCIAL STATEMENTS
INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF MARCH 31, 2025
TABLE OF CONTENTS
| Page | |
|---|---|
| CONSOLIDATED FINANCIAL STATEMENTS: | |
| Condensed Consolidated Balance sheets | 2 |
| Condensed Consolidated Statements of Comprehensive Income (loss) | 3 |
| Condensed Consolidated Statements of Changes in Equity | 4 |
| Condensed Consolidated Statements of Cash Flows | 5 |
| Notes to Condensed Consolidated Financial Statements | 6-25 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.